来源： 类型：
中国对外经济贸易文告2004年第四十二期
商务部规章及政策措施
各部门和地方有关规章及政策措施
1、中华人民共和国海关总署令第114号，发布《中华人民共和国海关关于〈中华人民共和国知识产权海关保护条例〉的实施办法》
2、中华人民共和国海关总署公告2004年第15号
3、中华人民共和国国家质量监督检验检疫总局、中华人民共和国国家认证认可监督管理委员会公告2004年第62号
4、国家食品药品监督管理局关于执行《关于全面监督实施药品GMP有关问题的通告》有关事项的通知
2、中华人民共和国海关总署公告2004年第15号
3、中华人民共和国国家质量监督检验检疫总局、中华人民共和国国家认证认可监督管理委员会公告2004年第62号
4、国家食品药品监督管理局关于执行《关于全面监督实施药品GMP有关问题的通告》有关事项的通知
Rules and Other Measures of the
Ministry of Commerce
Ministry of Commerce
1. Announcement on the Tendering in Agreement for Export Quota of Talcum Block (Powder) in 2004
2. Announcement on the Open Tendering for Export Quota of Talcum Block (Powder) in 2004
2. Announcement on the Open Tendering for Export Quota of Talcum Block (Powder) in 2004
Department Rules and Other Measures of
Government Departments and Local Governments
Government Departments and Local Governments
1. Decree No.114 of the General Administration of Customs of the People's Republic of China, Promulgating the Measures of the Customs of the People's Republic of China on Implementing the Regulations of the People's Republic of China on Customs Protection of Intellectual Property
2. Announcement No.15, 2004 of the General Administration of Customs of the People's Republic of China
3. Announcement No.62, 2004 of the General Administration of Quality Supervision, Inspection and Quarantine, the Certification and Accreditation Administration of the People's Republic of China
4. Circular of the State Food and Drug Administration of the People's Republic of China, on Issues Concerning the Implementation of the Notification on Issues of the Supervision and Enforcement of Drug GMP in an All-Round Way
2. Announcement No.15, 2004 of the General Administration of Customs of the People's Republic of China
3. Announcement No.62, 2004 of the General Administration of Quality Supervision, Inspection and Quarantine, the Certification and Accreditation Administration of the People's Republic of China
4. Circular of the State Food and Drug Administration of the People's Republic of China, on Issues Concerning the Implementation of the Notification on Issues of the Supervision and Enforcement of Drug GMP in an All-Round Way
